Biomarkers predict effectiveness of radiation treatments for cancer

http://feeds.feedburner.com/~r/sciencedaily/top_news/top_health/~4/1v4BlCvubnc

An international team of researchers, led by Beaumont Health System’s Jan Akervall, M.D., Ph.D., looked at biomarkers to determine the effectiveness of radiation treatments for patients with squamous cell cancer of the head and neck. They identified two markers that were good at predicting a patient’s resistance to radiation therapy. Their findings were published in the February issue of the European Journal of Cancer.Explains Dr. Akervall, co-director, Head and Neck Cancer Multidisciplinary Clinic, Beaumont Hospital, Royal Oak, and clinical director of Beaumont’s BioBank, “Radiation therapy is a common treatment for people with squamous cell cancer of the head and neck. However, it’s not always well-tolerated. It can take two months, resulting in lots of side effects. Some of these complications are permanent. Before my patient goes down that path, I really want to know if their tumors are going to respond to radiation. That’s where the patient’s biomarkers can shed some light. If not, we can look at other treatment options — saving time, possible risk for complications and expense.”A biomarker is a gene or a set of genes or its products, RNA and proteins, that researchers use to predict a key clinical issue such as diagnosis, prognosis, and response to treatment, choice of treatment or recurrence. …


Read More: Biomarkers predict effectiveness of radiation treatments for cancer